Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6THP

Neprilysin in complex with the inhibitor (R)-4-(1-carboxy-3-(3'-chlorobiphenyl-4-yl)propan-2-ylamino)-4-oxobutanoic acid

6THP の概要
エントリーDOI10.2210/pdb6thp/pdb
分子名称Neprilysin, 2-acetamido-2-deoxy-beta-D-glucopyranose, ZINC ION, ... (5 entities in total)
機能のキーワードinhibitor, complex, hydrolase
由来する生物種Homo sapiens (Human)
タンパク質・核酸の鎖数2
化学式量合計161731.16
構造登録者
Schiering, N.,Wiesmann, C. (登録日: 2019-11-21, 公開日: 2020-02-12, 最終更新日: 2024-11-13)
主引用文献Kawanami, T.,Karki, R.G.,Cody, E.,Liu, Q.,Liang, G.,Ksander, G.M.,Rigel, D.F.,Schiering, N.,Gong, Y.,Coppola, G.M.,Iwaki, Y.,Sun, R.,Neubert, A.,Fan, L.,Ingles, S.,D'Arcy, A.,Villard, F.,Ramage, P.,Jeng, A.Y.,Leung-Chu, J.,Liu, J.,Beil, M.,Fu, F.,Chen, W.,Cumin, F.,Wiesmann, C.,Mogi, M.
Structure-Guided Design of Substituted Biphenyl Butanoic Acid Derivatives as Neprilysin Inhibitors.
Acs Med.Chem.Lett., 11:188-194, 2020
Cited by
PubMed Abstract: Inhibition of neprilysin (NEP) is widely studied as a therapeutic target for the treatment of hypertension, heart failure, and kidney disease. Sacubitril/valsartan (LCZ696) is a drug approved to reduce the risk of cardiovascular death in heart failure patients with reduced ejection fraction. LBQ657 is the active metabolite of sacubitril and an inhibitor of NEP. Previously, we have reported the crystal structure of NEP bound with LBQ657, whereby we noted the presence of a subsite in S1' that has not been explored before. We were also intrigued by the zinc coordination made by one of the carboxylic acids of LBQ657, leading us to explore alternative linkers to efficiently engage zinc for NEP inhibition. Structure-guided design culminated in the synthesis of selective, orally bioavailable, and subnanomolar inhibitors of NEP. A 17-fold boost in biochemical potency was observed upon addition of a chlorine atom that occupied the newly found subsite in S1'. We report herein the discovery and preclinical profiling of compound , which paved the path to our clinical candidate.
PubMed: 32071687
DOI: 10.1021/acsmedchemlett.9b00578
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.54 Å)
構造検証レポート
Validation report summary of 6thp
検証レポート(詳細版)ダウンロードをダウンロード

248636

件を2026-02-04に公開中

PDB statisticsPDBj update infoContact PDBjnumon